The extracellular matrix (ECM) constitutes a three-dimensional macromolecular framework that lies outside cells in most animal tissues and plays vital roles in cell adhesion, migration, differentiation, proliferation and survival. ECM comprises collagen, elastic fibers, reticular fibers and ground substance. It is an essential component of human skin that acts as a scaffold on which the entire epidermis settles and provides structural integrity. The ECM finds extensive application in wound care management, soft tissue reinforcement, plastic surgery, cardio surgery, vascular surgery and tissue regeneration. It is used in the form of hyaluronic acid gels, collagen patches, acellular tissue matrices and other biomaterials.

The global extracellular matrix market is estimated to be valued at US$ 46.12 Bn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics
Rising incidence of diabetic ulcers and other chronic wounds is a major driver of the extracellular matrix market. Moreover, the growing geriatric population that is more prone to injuries and surgical procedures also supports market growth. According to estimates by the United Nations, the population aged 60 years and above is expected to double from 12% to 22% between 2015 and 2050. The extracellular matrix finds application in repair and regeneration of damaged skin, soft tissues and internal organs, thereby witnessing high demand. Additionally, the growing need for effective wound care solutions and availability of advanced ECM-based products are projected to propel the market during the forecast period. However, stringent regulations governing tissue-engineered products and high costs associated with ECM development may restrain the market to a certain extent.

SWOT Analysis
Strength: Extracellular matrix market forecast is at a growing stage as it offers several benefits in wound healing and tissue regeneration. The major advantage is minimizing scarring during healing process which is in high demand. ECM products are composed of native tissue proteins and growth factors which aids in natural healing process. They mimic the natural cellular environment and support tissue regeneration.
Weakness: High costs associated with advanced ECM products limit their uptake in developing regions where cost sensitivity is high. Also, limited clinical evidence and stringent regulations further delay product commercialization.
Opportunity: Increasing cases of chronic wounds, diabetes, and trauma injuries creates opportunities for market players. Also, growing geriatric population which is at higher risk of injuries and chronic conditions expands the customer base. Emergence of bio-engineered ECM products offers greater customization as per application.
Threats: Alternative therapies like skin grafts and flaps pose competition. Presence of local manufacturers offering low cost substitutes impacts sales of leading brands. Stricter norms can temporarily stall new product approvals.

Key Takeaways

The global extracellular matrix market is expected to witness high growth in the forecast period of 2023 to 2030. The market size is projected to increase from US$ 46.12 Bn in 2023 to over US$ 74 Bn by 2030 at a CAGR of 5.1%.

Regional analysis: North America dominates the ECM market currently owing to supportive reimbursement policies and robust healthcare infrastructure. However, Asia Pacific region is emerging as the fastest growing market with growing medical tourism and rapid economic development in countries like China and India.

Key players: Key players operating in the extracellular matrix market are VISUfarma, Johnson & Johnson, Otsuka Holdings Co. Ltd., OASIS Medical, Novartis AG, Sentiss Pharma Pvt. Ltd., AbbVie Inc. (Allergan PLC), Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd., among others. These leading brands are focused on expanding their product portfolios through acquisitions and new product launches.

Get more insights on this topic: https://www.trendingwebwire.com/extracellular-matrix-market-industry-insights-trendsextracellular-matrix-market-2023-2030/